Northern Trust’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-324,786
Closed -$601K 4651
2023
Q1
$601K Sell
324,786
-31,852
-9% -$58.9K ﹤0.01% 3388
2022
Q4
$396K Buy
356,638
+23,482
+7% +$26.1K ﹤0.01% 3579
2022
Q3
$779K Sell
333,156
-56,124
-14% -$131K ﹤0.01% 3371
2022
Q2
$1.18M Buy
389,280
+56,692
+17% +$172K ﹤0.01% 3301
2022
Q1
$2.26M Sell
332,588
-14,134
-4% -$96K ﹤0.01% 3043
2021
Q4
$2.89M Sell
346,722
-3,925
-1% -$32.8K ﹤0.01% 3028
2021
Q3
$2.61M Sell
350,647
-77,238
-18% -$574K ﹤0.01% 3137
2021
Q2
$2.91M Buy
427,885
+175,285
+69% +$1.19M ﹤0.01% 3173
2021
Q1
$2.59M Sell
252,600
-61,040
-19% -$627K ﹤0.01% 3112
2020
Q4
$2.2M Buy
313,640
+4,069
+1% +$28.5K ﹤0.01% 3154
2020
Q3
$2.53M Sell
309,571
-13,601
-4% -$111K ﹤0.01% 2946
2020
Q2
$2.23M Buy
323,172
+126,893
+65% +$876K ﹤0.01% 2985
2020
Q1
$932K Buy
196,279
+23,686
+14% +$112K ﹤0.01% 3247
2019
Q4
$1.51M Sell
172,593
-8,164
-5% -$71.3K ﹤0.01% 3254
2019
Q3
$602K Sell
180,757
-8,606
-5% -$28.7K ﹤0.01% 3510
2019
Q2
$937K Buy
189,363
+5,604
+3% +$27.7K ﹤0.01% 3379
2019
Q1
$1.14M Sell
183,759
-65
-0% -$403 ﹤0.01% 3314
2018
Q4
$619K Sell
183,824
-1,855
-1% -$6.25K ﹤0.01% 3506
2018
Q3
$1.21M Buy
185,679
+24,322
+15% +$158K ﹤0.01% 3423
2018
Q2
$1.24M Buy
161,357
+15,684
+11% +$120K ﹤0.01% 3404
2018
Q1
$3.26M Sell
145,673
-4,512
-3% -$101K ﹤0.01% 2836
2017
Q4
$1.92M Buy
150,185
+5,606
+4% +$71.5K ﹤0.01% 3163
2017
Q3
$2.25M Buy
144,579
+54,167
+60% +$844K ﹤0.01% 3101
2017
Q2
$1.27M Buy
90,412
+57,120
+172% +$802K ﹤0.01% 3374
2017
Q1
$732K Buy
+33,292
New +$732K ﹤0.01% 3439